MUMBAI: GPT Healthcare Ltd, which runs chain of ILS hospitals, has filed a draft letter seeking approval of the Securities Exchange Board of India (SEBI) to raise funds through an initial public offering.IPO)
IPO involves a new issue ₹17.50 crore and Offer for Sale (OFS) of 29.89 million shares by its existing shareholders and promoters.
The OFS consists of 3.80 million shares held by GPT Sons Pvt. and to 26.08 million by Burntree Growth Capital II LLC. The proceeds from the issue will be used to purchase medical equipment.
DAM Capital and SBI Capital Markets are the lead managers of the issue.
GPT Healthcare operates a chain of medium-sized multispecialty hospitals in eastern India under the ILS Hospitals brand and provides integrated healthcare services with a focus on secondary and tertiary care.
As of September 2021, the firm has four multispecialty hospitals with a total capacity of 556 beds.
It provides a range of health services including internal medicine and diabetology, nephrology (including kidney transplantation), laparoscopic and general surgery, gynecology and obstetrics, critical care, gastroenterology, orthopedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology. Offers wide range. .
Each of its hospitals also provides integrated clinical services and pharmacies that serve our patients. It also provides outpatient services including counseling for a variety of ailments and preventive health checkups.
Dr. Om Tantia, the founder of ILS Hospital and one of its promoters is an established name in the field of laparoscopic surgery. Dr Tantia has 40 years of experience in Minimal Access Surgery and established ILS Hospital in 2000.
For the financial year 2021, the total income was ₹248.86 crore against ₹216.08 crore a year ago. net profit for the period ₹21.09 Cr Vs. ₹10.96 crore a year ago. As of September 2021, its total borrowings was ₹113.25 crores.
Don’t miss a story! Stay connected and informed with Mint.
download
Our App Now!!
.